堃博医疗-B（02216.HK）今日盘中大跌5.41%，引发市场关注。这一显著跌幅与公司昨日晚间发布的2025年中期业绩报告密切相关。
根据堃博医疗-B发布的财报显示，截至2025年6月30日的六个月内，公司收入为165.2万美元，同比大幅下降55.4%。尽管净亏损相比去年同期小幅收窄1.9%，达到779.2万美元，但毛利也出现显著下滑，为121.4万美元，同比减少58.9%。
分析人士指出，虽然公司在控制成本方面略有成效，使得净亏损有所收窄，但收入和毛利的大幅下滑表明公司在市场拓展和盈利能力方面面临严峻挑战。这份疲软的财务报告很可能是导致投资者信心受挫，引发今日股价大跌的主要原因。市场将继续关注堃博医疗-B未来的业务发展策略及其在医疗器械行业的竞争力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.